BackBristol-Myers Squibb Overview

Bristol-Myers Squibb Current Cash

Track Bristol-Myers Squibb's current cash ($8.7B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$8.72B
↓ 30.77% YoYΔ $-3.88B vs prior year quarter

Peer average

Loading

Bristol-Myers Squibb Current Cash History

Loading

Bristol-Myers Squibb vs. peers: Current Cash Comparison

Loading

Bristol-Myers Squibb Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bristol-Myers Squibb (BMY) FAQ

Bristol-Myers Squibb (BMY) currently reports a current cash of $8.7B as of June 2026. That compares with $13B in the prior-year period — down 30.8% year over year. Use the charts on this page to explore Bristol-Myers Squibb's current cash history and peer comparisons.

Bristol-Myers Squibb's current cash decreased from $13B to $8.7B — a 30.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bristol-Myers Squibb reported $8.7B in current cash as of June 2026. That compares with $13B in the prior-year period — down 30.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $8.7B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bristol-Myers Squibb, and consider following BMY for alerts when major investors trade the stock.

Bristol-Myers Squibb is classified in the Healthcare sector. On current cash, it currently shows $8.7B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BMY with unrelated industries.